|
1
|
Shimizu M, Tanaka T and Moriwaki H:
Obesity and hepatocellular carcinoma: Targeting obesity-related
inflammation for chemoprevention of liver carcinogenesis. Semin
Immunopathol. 35:191–202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sakai H, Shirakami Y and Shimizu M:
Chemoprevention of obesity-related liver carcinogenesis using
pharmaceutical and nutraceutical agents. World J Gastroenterol.
22:394–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dhanasekaran R, Limaye A and Cabrera R:
Hepatocellular carcinoma: Current trends in worldwide epidemiology,
risk factors, diagnosis, and therapeutics. Hepat Med. 4:19–37.
2012.PubMed/NCBI
|
|
4
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA, Liu CG, Ferracin M, Hyslop T,
Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et
al: Ultraconserved regions encoding ncRNAs are altered in human
leukemias and carcinomas. Cancer Cell. 12:215–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arvey A, Larsson E, Sander C, Leslie CS
and Marks DS: Target mRNA abundance dilutes microRNA and siRNA
activity. Mol Syst Biol. 6:3632010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ebert MS and Sharp PA: Emerging roles for
natural microRNA sponges. Curr Biol. 20:R858–R861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao
Z, Zhi H, Wang T, Guo Z and Li X: Identification of
lncRNA-associated competing triplets reveals global patterns and
prognostic markers for cancer. Nucleic Acids Res. 43:3478–3489.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao Y, Wang P, Ning S, Xiao W, Xiao B and
Li X: Identification of prognostic biomarkers in glioblastoma using
a long non-coding RNA-mediated, competitive endogenous RNA network.
Oncotarget. 7:41737–41747. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with microRNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang P, Zhi H, Zhang Y, Liu Y, Zhang J,
Gao Y, Guo M, Ning S and Li X: miRSponge: A manually curated
database for experimentally supported miRNA sponges and ceRNAs.
Database. 2015(pii): bav0982015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu J, Li Y, Lu J, Pan T, Ding N, Wang Z,
Shao T, Zhang J, Wang L and Li X: The mRNA related ceRNA-ceRNA
landscape and significance across 20 major cancer types. Nucleic
Acids Res. 43:8169–8182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giza DE, Vasilescu C and Calin GA:
MicroRNAs and ceRNAs: Therapeutic implications of RNA networks.
Expert Opin Biol Ther. 14:1285–1293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu K, Yan Z, Li Y and Sun Z: Linc2GO: A
human lincRNA function annotation resource based on ceRNA
hypothesis. Bioinformatics. 29:2221–2222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Das S, Ghosal S, Sen R and Chakrabarti J:
lnCeDB: Database of human long noncoding RNA acting as competing
endogenous RNA. PLoS One. 9:e989652014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng T, Chou J, Zhang F, Liu Y, Ni H, Li
X, Zheng L, Tang T, Jin L and Xi T: CXCR4 3′UTR functions as a
ceRNA in promoting metastasis, proliferation and survival of MCF-7
cells by regulating miR-146a activity. Eur J Cell Biol. 94:458–469.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang K, Li Q, Kang X, Wang Y and Wang S:
Identification and functional characterization of lncRNAs acting as
ceRNA involved in the malignant progression of glioblastoma
multiforme. Oncol Rep. 36:2911–2925. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei C, Luo T, Zou S, Zhou X, Shen W, Ji X,
Li Q and Wu A: Differentially expressed lncRNAs and miRNAs with
associated ceRNA networks in aged mice with postoperative cognitive
dysfunction. Oncotarget. 8:55901–55914. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kersey PJ, Lawson D, Birney E, Derwent PS,
Haimel M, Herrero J, Keenan S, Kerhornou A, Koscielny G, Kähäri A,
et al: Ensembl Genomes: Extending Ensembl across the taxonomic
space. Nucleic Acids Res. 38:D563–D569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schulze K, Imbeaud S, Letouzé E,
Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C,
Shinde J, Soysouvanh F, et al: Exome sequencing of hepatocellular
carcinomas identifies new mutational signatures and potential
therapeutic targets. Nat Genet. 47:505–511. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hofmann E, Muller J and Schuknecht B:
Glomus tumor? Aberrant internal carotid artery. Radiologe.
30:555–556. 1990.(In German). PubMed/NCBI
|
|
26
|
Koshland DE Jr: Health care: More access
and more cures. Science. 262:14951993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pang EY, Bai AH, To KF, Sy SM, Wong NL,
Lai PB, Squire JA and Wong N: Identification of PFTAIRE protein
kinase 1, a novel cell division cycle-2 related gene, in the motile
phenotype of hepatocellular carcinoma cells. Hepatology.
46:436–445. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu X, Jiang C, Wang S, Tai Y, Wang T, Kang
L, Fan Z, Li S, Li L, Fu J, et al: HPIP is upregulated in liver
cancer and promotes hepatoma cell proliferation via activation of
G2/M transition. IUBMB Life. 65:873–882. 2013.PubMed/NCBI
|
|
29
|
Yan H, Li Z, Shen Q, Wang Q, Tian J, Jiang
Q and Gao L: Aberrant expression of cell cycle and material
metabolism related genes contributes to hepatocellular carcinoma
occurrence. Pathol Res Pract. 213:316–321. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yasuda E, Kumada T, Takai S, Ishisaki A,
Noda T, Matsushima-Nishiwaki R, Yoshimi N, Kato K, Toyoda H,
Kaneoka Y, et al: Attenuated phosphorylation of heat shock protein
27 correlates with tumor progression in patients with
hepatocellular carcinoma. Biochem Biophys Res Commun. 337:337–342.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang M, Wang W, Li T, Yu X, Zhu Y, Ding
F, Li D and Yang T: Long noncoding RNA SNHG1 predicts a poor
prognosis and promotes hepatocellular carcinoma tumorigenesis.
Biomed Pharmacother. 80:73–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 4:721–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang G and Tang X: Short tandem target
mimic: A long journey to the engineered molecular landmine for
selective destruction/blockage of microRNAs in plants and animals.
J Genet Genomics. 40:291–296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tang G, Yan J, Gu Y, Qiao M, Fan R, Mao Y
and Tang X: Construction of short tandem target mimic (STTM) to
block the functions of plant and animal microRNAs. Methods.
58:118–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei Y, Chang Z, Wu C, Zhu Y, Li K and Xu
Y: Identification of potential cancer-related pseudogenes in lung
adenocarcinoma based on ceRNA hypothesis. Oncotarget.
8:59036–59047. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu H, Wu R, Chen M, Li D, Dai J, Zhang Y,
Gao K, Yu J, Hu G, Guo Y, et al: Comprehensive analysis of
differentially expressed profiles of lncRNAs and construction of
miR-133b mediated ceRNA network in colorectal cancer. Oncotarget.
8:21095–21105. 2017.PubMed/NCBI
|
|
38
|
Su X, Xing J, Wang Z, Chen L, Cui M and
Jiang B: microRNAs and ceRNAs: RNA networks in pathogenesis of
cancer. Chin J Cancer Res. 25:235–239. 2013.PubMed/NCBI
|
|
39
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li Y, Chen D, Gao X, Li X and Shi G:
LncRNA NEAT1 regulates cell viability and invasion in esophageal
squamous cell carcinoma through the miR-129/CTBP2 axis. Dis
Markers. 2017:53146492017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.PubMed/NCBI
|
|
42
|
Liu H, Li J, Koirala P, Ding X, Chen B,
Wang Y, Wang Z, Wang C, Zhang X and Mo YY: Long non-coding RNAs as
prognostic markers in human breast cancer. Oncotarget.
7:20584–20596. 2016.PubMed/NCBI
|
|
43
|
Li Z, Shen J, Chan MT and Wu WK: TUG1: A
pivotal oncogenic long non-coding RNA of human cancers. Cell
Prolif. 49:471–475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang MD, Chen WM, Qi FZ, Sun M, Xu TP, Ma
P and Shu YQ: Long non-coding RNA TUG1 is up-regulated in
hepatocellular carcinoma and promotes cell growth and apoptosis by
epigenetically silencing of KLF2. Mol Cancer. 14:1652015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sunamura N, Ohira T, Kataoka M, Inaoka D,
Tanabe H, Nakayama Y, Oshimura M and Kugoh H: Regulation of
functional KCNQ1OT1 lncRNA by β-catenin. Sci Rep.
6:206902016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang Z, Weaver DL, Olsen D, deKay J, Peng
Z, Ashikaga T and Evans MF: Long non-coding RNA chromogenic in situ
hybridisation signal pattern correlation with breast tumour
pathology. J Clin Pathol. 69:76–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wan J, Huang M, Zhao H, Wang C, Zhao X,
Jiang X, Bian S, He Y and Gao Y: A novel tetranucleotide repeat
polymorphism within KCNQ1OT1 confers risk for hepatocellular
carcinoma. DNA Cell Biol. 32:628–634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim J, Abdelmohsen K, Yang X, De S,
Grammatikakis I, Noh JH and Gorospe M: LncRNA OIP5-AS1/cyrano
sponges RNA-binding protein HuR. Nucleic Acids Res. 44:2378–2392.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang N, Chen J, Zhang H, Wang X, Yao H,
Peng Y and Zhang W: LncRNA OIP5-AS1 loss-induced microRNA-410
accumulation regulates cell proliferation and apoptosis by
targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple
myeloma. Cell Death Dis. 8:e29752017. View Article : Google Scholar : PubMed/NCBI
|
